Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 74

1.

Effect of latanoprost on central corneal thickness in unilateral normal-tension glaucoma.

You JY, Cho BJ.

J Ocul Pharmacol Ther. 2013 Apr;29(3):335-8. doi: 10.1089/jop.2012.0080. Epub 2012 Oct 17.

PMID:
23075402
2.

Long-term effect of latanoprost on central corneal thickness in normal-tension glaucoma: five-year follow-up results.

Lee H, Cho BJ.

J Ocul Pharmacol Ther. 2015 Apr;31(3):152-5. doi: 10.1089/jop.2014.0109. Epub 2015 Jan 26.

PMID:
25621500
3.

Long-term effect of latanoprost on central corneal thickness in normal tension glaucoma.

Kim HJ, Cho BJ.

J Ocul Pharmacol Ther. 2011 Feb;27(1):73-6. doi: 10.1089/jop.2010.0071. Epub 2010 Nov 23.

PMID:
21091278
4.

Change in Central Corneal Thickness After the Discontinuation of Latanoprost in Normal Tension Glaucoma-Change in Central Corneal Thickness After Stop of Latanoprost.

Yoo R, Choi YA, Cho BJ.

J Ocul Pharmacol Ther. 2017 Jan/Feb;33(1):57-61. doi: 10.1089/jop.2016.0036. Epub 2016 Nov 9.

PMID:
27828721
5.

Efficacy and safety of switching from topical latanoprost to bimatoprost in patients with normal-tension glaucoma.

Sato S, Hirooka K, Baba T, Mizote M, Fujimura T, Tenkumo K, Ueda H, Shiraga F.

J Ocul Pharmacol Ther. 2011 Oct;27(5):499-502. doi: 10.1089/jop.2011.0020. Epub 2011 Jul 26.

PMID:
21790301
6.

Longitudinal effect of topical antiglaucoma medications on central corneal thickness.

Viswanathan D, Goldberg I, Graham SL.

Clin Exp Ophthalmol. 2013 May-Jun;41(4):348-54. doi: 10.1111/j.1442-9071.2012.02870.x.

PMID:
22958109
7.

Effects of long-term topical prostaglandin therapy on central corneal thickness.

Maruyama Y, Mori K, Ikeda Y, Ueno M, Kinoshita S.

J Ocul Pharmacol Ther. 2014 Jun;30(5):440-4. doi: 10.1089/jop.2013.0196. Epub 2014 Apr 16.

PMID:
24738848
8.

The Effect of Long-term Antiglaucomatous Drug Administration on Central Corneal Thickness.

Schrems WA, Schrems-Hoesl LM, Mardin CY, Horn FK, Juenemann AG, Kruse FE, Braun JM, Laemmer R.

J Glaucoma. 2016 Mar;25(3):274-80. doi: 10.1097/IJG.0000000000000190.

PMID:
25383467
9.

Intraocular pressure (IOP) reduction by latanoprost in Japanese normal tension glaucoma patients over a five-year period stratified by presenting IOP.

Tsuda M, Ando A, Matsuyama K, Otsuji T, Fukui C, Maenishi N, Kuwahara A, Nishimura T, Jo N, Nambu H, Matsumura M.

J Ocul Pharmacol Ther. 2009 Oct;25(5):441-5. doi: 10.1089/jop.2008.0097.

PMID:
19857106
10.

Long-term effects of latanoprost monotherapy on intraocular pressure in Japanese glaucoma patients.

Kashiwagi K, Tsumura T, Tsukahara S.

J Glaucoma. 2008 Dec;17(8):662-6. doi: 10.1097/IJG.0b013e318166656d.

PMID:
19092463
11.

Long term effect of latanoprost on intraocular pressure in normal tension glaucoma.

Ang A, Reddy MA, Shepstone L, Broadway DC.

Br J Ophthalmol. 2004 May;88(5):630-4.

12.

Clinical experience in the treatment of normal tension glaucoma with latanoprost in Germany.

Thelen U, Weiler W, Kirchhoff E, Fuchs HB, Stewart WC.

J Ocul Pharmacol Ther. 2007 Jun;23(3):311-3.

PMID:
17593016
13.
14.
15.

The impact of common classes of topical antiglaucoma medications on central corneal thickness--own observations.

Wierzbowska J, Łagocka A, Siemiatkowska A, Robaszkiewicz J, Stankiewicz A, Sierdziński J.

Klin Oczna. 2009;111(10-12):323-6.

PMID:
20169887
16.

Significance of corneal biomechanical properties in patients with progressive normal-tension glaucoma.

Park JH, Jun RM, Choi KR.

Br J Ophthalmol. 2015 Jun;99(6):746-51. doi: 10.1136/bjophthalmol-2014-305962. Epub 2015 Jan 2.

PMID:
25555704
17.

Long-term effect of BAK-free travoprost on ocular surface and intraocular pressure in glaucoma patients after transition from latanoprost.

Aihara M, Otani S, Kozaki J, Unoki K, Takeuchi M, Minami K, Miyata K.

J Glaucoma. 2012 Jan;21(1):60-4. doi: 10.1097/IJG.0b013e3181fc8129.

PMID:
21278589
18.

Travoprost compared with latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.

Netland PA, Landry T, Sullivan EK, Andrew R, Silver L, Weiner A, Mallick S, Dickerson J, Bergamini MV, Robertson SM, Davis AA; Travoprost Study Group.

Am J Ophthalmol. 2001 Oct;132(4):472-84.

PMID:
11589866
19.
20.

Supplemental Content

Support Center